kabutan

Kohjin Bio Co.,Ltd.(177A) Summary

177A
TSE Growth
Kohjin Bio Co.,Ltd.
1,237
JPY
-20
(-1.59%)
Mar 13, 3:30 pm JST
7.76
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
18.8
PBR
1.07
Yield
0.81%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,257 JPY 7.89 USD
Previous Close Mar 12
1,257 JPY 7.90 USD
High Mar 13, 9:00 am
1,257 JPY 7.89 USD
Low Mar 13, 9:00 am
1,210 JPY 7.60 USD
Volume
2,300
Trading Value
3.00M JPY 0.02M USD
VWAP
1233.35 JPY 7.75 USD
Minimum Trading Value
123,700 JPY 776 USD
Market Cap
6.32B JPY 0.04B USD
Number of Trades
14
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
50
1-Year High Aug 27, 2025
1,762
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 79,600
Feb 27, 2026 0 80,600
Feb 20, 2026 0 79,500
Feb 13, 2026 200 78,300 391.50
Feb 6, 2026 0 78,400
Company Profile
Kohjin Bio Co., Ltd. specializes in the development, manufacturing, and sales of cell culture media, as well as contract manufacturing of cell-processed products.
Sector
Chemicals
Kohjin Bio Co., Ltd. primarily focuses on the manufacturing and sales of bacterial culture media, in vitro diagnostic pharmaceuticals, and cell culture media, while also emphasizing regenerative medicine. The company particularly concentrates on developing and selling serum-free media, providing culture media for stem cells and immune cells. Additionally, they manufacture and sell antigen test kits for COVID-19 and influenza. In their cell processing business, Kohjin Bio manufactures specific cell-processed products commissioned by medical institutions and offers regulatory compliance support for regenerative medicine. Working in collaboration with domestic and international group companies, Kohjin Bio provides a wide range of products and services related to microbial testing and regenerative medicine.